Organisation paid for research Program year 2023 Source: CMS Open Payments

Troy Gastroenterology PC

Neither a doctor nor a teaching hospital

Research payments

$358,530

142 payments

Through program year 2023, Troy Gastroenterology PC is reported as receiving $358,530 in research payments, across 142 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$254	2
2022	Research	$57,862	28
2021	Research	$32,899	19
2020	Research	$192,817	57
2019	Research	$74,697	36

Breakdown

Who paid Research payments · program years 2019–2023

AbbVie, Inc. $171,674 39 payments
Roche Products Limited $71,720 42 payments
Genentech, Inc. $54,380 29 payments
Pfizer Inc. $40,455 27 payments
Takeda Pharmaceuticals U.S.A., Inc. $10,340 1 payment
Janssen Research & Development, LLC $9,960 4 payments

Studies the money was for Research payments · program years 2019–2023

Crohn S Disease Program Cohort 1 Induction Cohort II Maintenance $49,923 32 payments
M14-533 $47,953 8 payments
A Phase 3B4multicenter Doubleblind Randomized Parallel Group Study of Tofacitinib Cp690550 in Subjects With Ulcerative Colitis in Stable Remission $30,899 15 payments
M16-000 $21,816 9 payments
Crohn S Disease Program Ole $21,797 10 payments
M14-433 $21,784 6 payments
Ada H2h Indxn 1 $21,509 6 payments
An Open Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II III Studies $17,073 12 payments
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis $12,151 3 payments
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) $11,427 3 payments

What the money was spent on Research payments · program years 2019–2023

Other $10,340 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.